Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Cancer pain drug approved for UK

  • Comment

A drug for treating “breakthrough” cancer pain has been approved for UK use by the European Medicines Agency.

Fentanyl pectin nasal spray (PecFent), manufactured by Archimedes Pharma, is indicated for treating breakthrough cancer pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.

Episodes of breakthrough cancer pain are severe to excruciating in intensity, and occur in people who are already taking strong, opioid painkillers. Episodes can often reach maximum intensity within five minutes, and typically last 30-60 minutes.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs